No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Why BioRestorative Therapies Stock Is Moving Higher Thursday
Pancreatic Cancer on the Rise: How Biotech Firms Are Developing Groundbreaking Treatments
Express News | Candel Therapeutics to Join Russell 3000® Index
Candel Therapeutics to Join Russell 3000 Index